Pathstone Family Office’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.73M Buy
7,904
+2,531
+47% +$573K 0.01% 501
2023
Q2
$1.21M Buy
5,373
+1,217
+29% +$244K 0.02% 424
2023
Q1
$805K Sell
4,156
-843
-17% -$163K 0.01% 512
2022
Q4
$823K Sell
4,999
-2,508
-33% -$441K 0.01% 503
2022
Q3
$1.25M Buy
7,507
+2,494
+50% +$507K 0.02% 338
2022
Q2
$1.03M Buy
5,013
+73
+1% +$16.5K 0.02% 336
2022
Q1
$1.47M Sell
4,940
-334
-6% -$77.4K 0.03% 236
2021
Q4
$1.28M Buy
5,274
+245
+5% +$56K 0.03% 277
2021
Q3
$1.03M Buy
5,029
+671
+15% +$144K 0.03% 284
2021
Q2
$899K Buy
+4,358
New +$877K 0.03% 298
2021
Q1
– Sell
-181
Closed -$34K – 1270
2020
Q4
$34K Buy
+181
New +$33.8K ﹤0.01% 591
2019
Q2
– Sell
-162
Closed -$21K – 875
2019
Q1
$21K Hold
162
– – ﹤0.01% 428
2018
Q4
$17K Buy
+162
New +$18.1K ﹤0.01% 279
2018
Q2
– Sell
-9
Closed -$1K – 313
2018
Q1
$1K Buy
+9
New +$818 ﹤0.01% 352

Other funds holding STE

Pathstone Family Office's STE Position: Q3 2023 in Review

Pathstone Family Office increased its Steris (STE) stake by 47% in Q3 2023, buying an estimated $573K and bringing the position to 7,904 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #501.

Pathstone Family Office first reported a position in STE in Q1 2018 and has held it in 14 quarters since. 682 funds tracked by Wall St. Rank hold STE as of Q3 2023.

  • Pathstone Family Office held 7,904 shares of Steris worth $1.73M as of Q3 2023.
  • Pathstone Family Office bought 2,531 Steris shares in Q3 2023, an estimated $573K.
  • Steris made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #501 holding.
  • Pathstone Family Office first reported a position in Steris in Q1 2018 and has held it in 14 quarters since.
  • 682 funds tracked by Wall St. Rank held Steris as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.